Scientists to gather in Lisbon to tackle next pandemic threats
John E. Kaye
- Published
- News

Nobel laureate Charles M. Rice joins experts examining emerging viruses, antibiotic resistance and engineered microbes
Some of the world’s leading microbiologists will meet in Lisbon to examine how microbes could shape the next pandemic, the future of medicine and the fight against antibiotic resistance.
Nobel Prize-winning virologist Charles M. Rice will join researchers including Yasmine Belkaid, Bonnie Bassler and Isabel Gordo for discussions on how microorganisms evolve, spread, communicate and affect human health.
The talks will focus on emerging viruses, antimicrobial resistance, bacterial evolution, host-microbe interactions and the use of biological engineering to turn microbes into tools for medicine, biotechnology and environmental protection.
Rice, of Rockefeller University, won the 2020 Nobel Prize in Medicine for work that helped identify the hepatitis C virus and enabled the development of effective antiviral treatments.
His appearance comes as researchers and governments continue to examine how better understanding of viruses can improve preparedness for future pandemics.
Yasmine Belkaid, president of the Institut Pasteur, will bring expertise in the microbiome and its relationship with the immune system.
Bonnie Bassler, of Princeton University, is known for her work on quorum sensing, the chemical communication system used by bacteria.
Isabel Gordo, of the Gulbenkian Institute for Molecular Medicine, studies how bacteria evolve inside the human body and how antibiotic resistance emerges.
The central question for the programme is how science can better understand microbes before they become larger threats.
Bacteria are constantly evolving, and many are becoming more resistant to medicines used to treat infection.
The World Health Organization has described antimicrobial resistance as one of the greatest threats to global health, with the potential to cause millions of deaths in the coming decades if effective action is not taken.
The programme, held under the theme Microbes – The Questions of the Future, will also explore how microbiome research is changing understanding of human health, and how engineered microorganisms could be used in prevention, diagnosis, treatment and environmental sustainability.
The discussions will take place during the second GIMM Festival, organised by the Gulbenkian Institute for Molecular Medicine from September 17 to 19.
Maria Manuel Mota, chief executive of the Gulbenkian Institute for Molecular Medicine, said: “The microscopic world has a profound impact on our health, ecosystems and the future of biotechnology.
“The GIMM Festival aims to bring researchers and society closer together to discuss how these discoveries can shape the future.”
READ MORE: Nobel laureate Omar Yaghi launches global science network. Research initiative will link institutions across seven countries to work on water scarcity, carbon capture, clean energy and climate resilience.
Do you have news to share or expertise to contribute? The European welcomes insights from business leaders and sector specialists. Get in touch with our editorial team to find out more.
Main image: Nobel laureate Charles M. Rice is joined by microbiologists Bonnie Bassler, Isabel Gordo and Yasmine Belkaid ahead of GIMM Fest 2026 in Lisbon, where experts will examine emerging viruses, antibiotic resistance and the future use of engineered microbes. Credits: GIMM Fest/The Gulbenkian Institute for Molecular Medicine; Staff Asbmb, CC BY 2.0; Riad S. Bereksi, CC BY-SA 4.0; John Sears, CC BY-SA 4.0.
TOP STORIES
-
Infront hires Deutsche Börse data expert Jeff Caldwell as AI transforms financial markets -
US rocket firm plans Scottish launches in bid to revive failed Highland spaceport -
Job adverts must reveal salaries under new ‘say what you pay’ law -
Ireland's most wanted jobs for 2027 revealed as employers offer higher salaries to attract talent -
American firms sign landmark deal to beam solar power from space as Europe faces AI energy crunch -
Europe’s winners and losers as Democrats seize Congress in crushing blow to Trump -
Spanish developer CLERHP reports US$410m in Caribbean property sales as profits return -
Britain launches first major study into ‘forever chemicals’ lurking in our bodies -
Scientists close in on mysterious ‘zeptoverse’ after 40-year hunt for ultra-rare particle -
Cambodia offers free sightseeing tours to stranded Villa Vie Odyssey passengers -
Bahrain lands $3.9bn investment deal with DHL, AirAsia and hotel giant Meliá -
Binance customers pull $3.6bn from crypto giant after record-breaking heist -
European bosses pocket 12 per cent pay rise as earnings gap with workers widens -
Businesses buying AI faster than they can make it pay, Manchester research finds -
Millions face ID and facial scans to use social media under UK age ban -
Denmark moves to ban ‘frankenchickens’ as UK faces calls to follow suit -
Jaguar Land Rover cyberattack was state-sponsored, former UK minister claims -
AI could 'help pharmaceutical companies spot clinical trial problems before they escalate' -
Raining cats and dogs? Brits have 17 ways to describe a downpour – and some are downright bizarre -
Rare jewellery returns to Japan after 50 years as German museum lends historic treasures to Kyoto -
Dan Brown drops tantalising hint about where his next thriller could be set -
Anthropic warns AI could pose ‘existential risks’ as it files for stock market flotation -
North Korean agents are infiltrating Western businesses by posing as employees, security chief warns -
Route 66 turns 100 next month – and there’s never been a better excuse for Europeans to hit the road -
Serbia erupts in celebration as student protesters end Vučić’s 14-year grip on power



























